Empirical Spine Completes Full Premarket Approval (PMA) Submisson to FDA for Limiflex™ Dynamic Sagittal Tether ™ — Empirical Spine
San Carlos, Calif. (December 19, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant, recently completed the final step in the U.S. Food & Drug Administration (FDA) submission process for the LimiFlex™ Dynamic Sagittal Tether™ (DST). The Premarket Approval (PMA) submission included Module III, with data and analysis […]